Skip to main content
All lobbying filings

FARRAGUT PARTNERS LLP

FARRAGUT PARTNERS LLP filed a Q1 report for ONEONCOLOGY LLC on April 20, 2026, reporting $50,000 in lobbying income.

Lobbying for ONEONCOLOGY LLC · Advocacy group for community oncology practices

All filings by FARRAGUT PARTNERS LLP · Everything ONEONCOLOGY LLC has reported

 Filing · LD-2 quarterly report Q1 report
Reporting period
1st Quarter 2026
Jan 1 - Mar 31 · Posted Apr 20, 2026
Income
$50,000
What the client paid this registrant for the period.
Client based in
Tennessee

Official filing document

 Lobbyists on this filing 7
  • JEFF MACKINNON
    Previously held: LD & LA Rep. Joe Barton (RTexas)
  • JEFFERY C. MORTIER
    Previously held: Prof Staff on E&C Cmte, LA Rep Whitfield and Intern Devin Nunes
  • SARAH WALTER
    Previously held: Former Legislative Director/Chief Counsel, Sen. John Breaux
  • EDWARD WHITFIELD
    Previously held: Member of Congress (KY 01), 21 yrs.
  • KRISTEN BAUTZ
    Previously held: Senior Advisor and Special Projects Coordinator, Rep Wasserman Shultz
  • DYLAN MOORE
    Previously held: Intern/Staff Assistant, Speaker John Boehner (OH-8); Legislative Assistant/Legislative Director/Deputy Chief of Staff, Rep. Larry Bucshon (IN-8); Intern, Rep. Mike Turner (OH-10)
  • CONSTANTINE HINGSON New on this filing
    Previously held: Chief of Staff, Senator Dan Coats; Counsel/Legislative Director, Senator Judd Gregg; General Counsel, Senator Elizabeth Dole

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

 Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 3

Issues pertaining to Medicare reimbursement. Issues pertaining to drug shortages, legislation regarding the 340B Drug discount program. Issues pertaining to sequestration; Issues related to pharmacy benefit managers. Drug Pricing legislation. Monitoring CMMI Demonstration Projects. CON regulations. CARES implementation.

Issues pertaining to Medicare reimbursement. Issues pertaining to drug shortages, legislation regarding the 340B Drug discount program. Issues pertaining to sequestration; Issues related to pharmacy benefit managers. Drug Pricing legislation. Monitoring CMMI Demonstration Projects. CON regulations. CARES implementation

Issues related to pharmacy benefit managers.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem